Redesign Health · 3 months ago
Managing Director, AI Venture Buyouts
Redesign Health
Full-time
Onsite
Director/Executive
10+ years expRedesign Health is a global asset management platform that empowers builders to launch and scale transformative health technology companies. They are seeking a Managing Director for AI Venture Buyouts to lead the full lifecycle of their strategy, focusing on healthcare control investments and utilizing artificial intelligence for transformation.
Artificial Intelligence (AI)Health CareMedicalSmall and Medium BusinessesVenture Capital
Responsibilities
Lead Redesign’s AI-driven buyout strategy focused on healthcare control investments
Build deal flow through a proprietary network of intermediaries, executives, and operators
Execute transactions end-to-end, overseeing diligence, modeling, and closing mechanics
Partner with AI and operating teams to deploy post-close transformation playbooks
Quantify and communicate impact of AI-driven operating leverage across portfolio companies
Participate in capital raising
Build and lead a high-performing investment team
Qualification
Required
10–15 years in healthcare private equity or growth equity, with experience leading control investments
Proven ability to originate, diligence, and close transactions in the healthcare sector
Strong network across healthcare executives, founders, intermediaries, and strategics
Fluency in LBO modeling, valuation, and transaction structuring
Demonstrated success driving value creation through operational and digital transformation
Experience raising capital and managing institutional investor relationships
Deep interest in how AI, automation, and data reshape cost structures and enterprise value
Execution Excellence: Process-oriented and rigorous in managing complex transactions
Influential Communicator: Commands credibility with LPs, boards, and management teams
AI-Literate Investor: Understands how emerging technologies drive structural advantage
Team Leader: Builds small, high-output teams that execute with precision and urgency
Track record driving measurable value creation in healthcare portfolio companies
Understanding of payer–provider dynamics, reimbursement, and healthcare regulation
Company
Redesign Health
Redesign Health is a global venture builder that empowers founders to launch and scale transformative healthcare companies.
51-200 employees
Funding
Current Stage
Growth StageTotal Funding
$315MKey Investors
General Catalyst
2022-09-13Series C· $65M
2020-03-25Series Unknown· $250M
Leadership Team
Brett Shaheen
Founder & CEO
Neil Patel
Head of Ventures
Recent News
Company data provided by crunchbase